News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Duvall Diantha
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/24/2023 |
4
| Duvall Diantha (CFO) has filed a Form 4 on CURIS INC|
Txns:
| Granted 500,000 options to buy
@ $0.7, valued at
$350k
|
|
| 08/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Sold 963 shares
@ $1.25, valued at
$1.2k
|
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2022 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 6,623 shares
@ $0
Granted 24,938 options to buy
@ $2.72, valued at
$67.8k
|
|
| 04/06/2020 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 12,299 shares
@ $0
Granted 46,313 options to buy
@ $1.66, valued at
$76.9k
|
|
| 03/07/2019 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 475,000 options to buy
@ $0.83, valued at
$394.3k
|
|
| 03/07/2019 |
3
| Duvall Diantha (CFO) has filed a Form 3 on GENOCEA BIOSCIENCES, INC. |
| 03/08/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 2,791 shares
@ $0
Disposed/sold 2,780 restricted stock units
@ $0
Disposed/sold 7,273 restricted stock units
@ $0
Disposed/sold 7,030 options to buy
@ $52.08, valued at
$366.1k
Disposed/sold 11,062 options to buy
@ $44.51, valued at
$492.4k
|
|
| 03/05/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 105 shares
@ $104.73, valued at
$11k
|
|
| 02/26/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 168 shares
@ $104.3, valued at
$17.5k
|
|
| 02/15/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 454 shares
@ $103.52, valued at
$47k
Exercised 1,390 restricted stock units
@ $0 |
|
| 02/02/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 7,273 restricted stock units
@ $0 |
|
| 06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/27/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/01/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|